OVERVIEW
The study predicts the short-term and long-term trends that can shape the future of structural heart devices market size that is expected to surpass USD 3.1 million by 2026 growing at a CAGR of 6.0 percent over the forecast period and this report will also account for Covid-19 implications as it acts as a key market contributor. Major factors contributing to the expansion of the worldwide market include the number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.
TABLE OF CONTENT
- 1 Global Hemostats Market
- 1.1 Study Objectives
- 1.2 Market Definition
- 1.3 Study Scope
- 1.3.1 Markets Covered
- 1.3.2 Geographic Scope
- 2 RESEARCH METHODOLOGY
- 2.1 Research Data
- 2.1.1 Secondary Data
- 2.1.1.1 Key Data From Secondary Sources
- 2.1.2 Primary Data
- 2.1.2.1 Key Data From Primary Sources
- 2.1.2.2 Key Industry Insights
- 2.1.2.3 Breakdown of Primaries
- 2.1.1 Secondary Data
- 2.2 Market Size Estimation
- 2.2.1 Bottom-Up Approach
- 2.2.2 Top-Down Approach
- 2.3 Market Breakdown and Data Triangulation
- 2.4 Research Assumptions
- 2.1 Research Data
- 3 Global Hemostats Market ? Executive Summary
- 3.1 Market Revenue, Market Size and Key Trends by Company
- 3.2 Key Trends by type of Application
- 3.3 Key Trends segmented by Geography
- 4 Global Hemostats Market ? Comparative Analysis
- 4.1 Product Benchmarking - Top 10 companies
- 4.2 Top 5 Financials Analysis
- 4.3 Market Value split by Top 10 companies
- 4.4 Patent Analysis - Top 10 companies
- 4.5 Pricing Analysis
- 5 Global Hemostats Market ? Industry Market Entry Scenario
- 5.1 Regulatory Framework Overview
- 5.2 New Business and Ease of Doing business index
- 5.3 Case studies of successful ventures
- 5.4 Customer Analysis ? Top 10 companies
- 6 Global Hemostats Market - Market Forces
- 6.1 Introduction
- 6.2 Market Dynamics
- 6.2.1 Drivers
- 6.2.2 Opportunities
- 6.2.3 Challenges
- 6.3 Porters Analysis of Market
- 6.3.1 Bargaining power of suppliers
- 6.3.2 Bargaining powers of customers
- 6.3.3 Threat of new entrants
- 6.3.4 Rivalry among existing players
- 6.3.5 Threat of substitutes
- 7 Global Hemostats Market - Strategic Analysis
- 7.1 Value Chain analysis
- 7.2 Product Life Cycle
- 7.3 Supplier and distributor analysis (Market share and product dealing strategies)
- 8 Global Hemostats Market ? By Product (Market Size ? & million/billion)
- 8.1 Thrombin-based hemostats
- 8.2 Oxidized regenerated cellulose based hemostats
- 8.3 Combination hemostats
- 8.4 Gelatin-based hemostats
- 8.5 Collagen-based hemostats
- 9 Global Hemostats Market - By Formulation
- 9.1 Matrix & gel hemostats
- 9.2 Sheet & pad hemostats
- 9.3 Sponge hemostats
- 9.4 Powder hemostats
- 10 Global Hemostats Market - By Application
- 10.1 Orthopedic surgery
- 10.2 General surgery
- 10.3 Neurological surgery
- 10.4 Cardiovascular surgery
- 10.5 Reconstructive surgery
- 10.6 Gynecological surgery
- 10.7 Other
- 11 Global Hemostats Market ? By Geography (Market Size ? & million/billion)
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 U.K
- 11.3.2 Germany
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia-Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Rest of APAC
- 11.5 Rest of the World
- 11.5.1 South America
- 11.5.2 Middle East
- 11.5.3 Africa
- 12 Global Hemostats Market ? Entropy
- 12.1 New product launches
- 12.2 M&A's, collaborations, JVs and partnerships
- 13 Global Hemostats Market Company Profile (Key Players)
- 13.1 Market Share, Company Revenue, Products, M&A, Developments
- 13.2 C. R. Bard
- 13.3 B.Braun
- 13.4 Baxter
- 13.5 Gelita Medical GmbH
- 13.6 Integra Lifesciences
- 13.7 Marine Polymer Technologies
- 13.8 Ethicon (Subsidiary of Johnson & Johnson)
- 13.9 Teleflex Incorporated
- 13.10 Pfizer
- 13.11 Z-Medica, LLC
- 13.12 Company 11 & more
- 14 Global Hemostats Market - Appendix
- 14.1 Sources
- 14.2 Abbreviations
Hemostats Market by Formulation (Matrix & Gel, Powder, Sheets & Pads), Product (Combination, Gelatin, Thrombin, Oxidised Regenerated Cellulose, Collagen), Application (Neurology, Gynecology, Reconstructive, Cardiovascular) ? 2022 to 2027
Category: HealthcareSKU: GMS-1217
×